Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma.
about
A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.Treatment-related symptom management in patients with multiple myeloma: a review.Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide.Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
P2860
Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evaluation of the pharmacokine ...... treatment of multiple myeloma.
@en
type
label
Evaluation of the pharmacokine ...... treatment of multiple myeloma.
@en
prefLabel
Evaluation of the pharmacokine ...... treatment of multiple myeloma.
@en
P2093
P2860
P1476
Evaluation of the pharmacokine ...... treatment of multiple myeloma
@en
P2093
Chiara Cerrato
Chiara Pautasso
Mario Boccadoro
Sara Bringhen
P2860
P304
P356
10.1517/17425255.2012.712685
P407
P577
2012-08-03T00:00:00Z